249 related articles for article (PubMed ID: 4547783)
1. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin.
Heck LW; Kaplan AP
J Exp Med; 1974 Dec; 140(6):1615-30. PubMed ID: 4547783
[TBL] [Abstract][Full Text] [Related]
2. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.
Saito H; Ratnoff OD; Marshall JS; Pensky J
J Clin Invest; 1973 Apr; 52(4):850-61. PubMed ID: 4266422
[TBL] [Abstract][Full Text] [Related]
3. Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
Harpel PC
J Clin Invest; 1971 Oct; 50(10):2084-90. PubMed ID: 5165598
[TBL] [Abstract][Full Text] [Related]
4. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
Takahashi H; Nagasawa S; Suzuki T
J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
[TBL] [Abstract][Full Text] [Related]
5. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
Cochrane CG; Wuepper KD
J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
[TBL] [Abstract][Full Text] [Related]
6. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator.
Kaplan AP; Austen KF
J Exp Med; 1972 Dec; 136(6):1378-93. PubMed ID: 4264575
[TBL] [Abstract][Full Text] [Related]
7. Conversion of Hageman factor (factor XII) of the guinea pig to prekallikrein activator and inhibition of the formed kallikrein by a natural plasma inhibitor.
Takeuchi Y; Movat HZ
Eur J Immunol; 1972 Aug; 2(4):345-9. PubMed ID: 4538864
[No Abstract] [Full Text] [Related]
8. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
Saito H
J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
[TBL] [Abstract][Full Text] [Related]
9. Factor XII-induced fibrinolysis: studies on the separation of prekallikrein, plasminogen proactivator, and factor XI in human plasma.
Laake K; Venneröd AM
Thromb Res; 1974 Feb; 4(2):285-302. PubMed ID: 4208626
[No Abstract] [Full Text] [Related]
10. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
Ratnoff OD; Saito H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
[TBL] [Abstract][Full Text] [Related]
11. [Isolation and some properties of Hageman factor and its active fragment from human blood].
Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
[TBL] [Abstract][Full Text] [Related]
12. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
Saito H; Ratnoff OD
Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of rat plasma kallikrein.
Bedi GS; Back N
Prep Biochem; 1984 Aug; 14(3):257-79. PubMed ID: 6567197
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor.
Griffin JH; Cochrane CG
Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2554-8. PubMed ID: 1066663
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of rat plasma alpha-1-antitrypsin.
Takahara H; Nakayama H; Sinohara H
J Biochem; 1980 Aug; 88(2):417-24. PubMed ID: 6968311
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a prealbumin activator of prekallikrein from acetone-activated human plasma.
Venneröd AM; Laake K
Thromb Res; 1974 Jan; 4(1):103-18. PubMed ID: 4829662
[No Abstract] [Full Text] [Related]
17. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.
Mashiko H; Kato K; Fujii K; Takahashi H
Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227
[TBL] [Abstract][Full Text] [Related]
18. A neutrophil-dependent pathway for the generation of a neutral peptide mediator: partial characterization of components and control by alpha-1-antitrypsin.
Wintroub BU; Goetzl EJ; Austen KF
J Exp Med; 1974 Sep; 140(3):812-24. PubMed ID: 4547125
[TBL] [Abstract][Full Text] [Related]
19. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
Treloar MP; Pyle H; Ozge-Anwar AH; Takeuchi Y; Movat HZ
Eur J Immunol; 1972 Aug; 2(4):338-45. PubMed ID: 5083514
[No Abstract] [Full Text] [Related]
20. Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf.
Scott CF; Carrell RW; Glaser CB; Kueppers F; Lewis JH; Colman RW
J Clin Invest; 1986 Feb; 77(2):631-4. PubMed ID: 3484755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
